Skip to content

Enhancing Radiation Safety for Nuclear Medicine Radiographers: the Impact of Introducing the Automat-ed Radiopharmaceutical Preparation and Administration System

Enhancing Radiation Safety for Nuclear Medicine Radiographers: the Impact of Introducing the Automated Radiopharmaceutical Preparation and Administration System

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06371703
Enrollment
100
Registered
2024-04-17
Start date
2024-10-31
Completion date
2024-10-31
Last updated
2024-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation Exposure

Brief summary

This project aims to evaluate the impact of the introduction of an automated system for radiopharmaceutical preparation and administration on the radiation safety of the radiographers working in nuclear medicine. This study will help to fill the existing gap in the scientific literature and provide useful guidance for the selection of the safest and most effective automated infusion system.

Interventions

RADIATIONautomated system in reducing radiation exposure

evaluate the effectiveness of the automated system in reducing radiation exposure for radiographers involved in PET/CT procedures.

Sponsors

IRCCS San Raffaele
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* 1)Nuclear medicine radiographers with experience in manual prepa-ration of radiopharmaceuticals. 2\) Nuclear medicine healthcare professionals with experience in radiopharmaceutical administration. 3\) Ability to provide written informed consent.

Exclusion criteria

* 1\) Nuclear medicine radiographers without experience in manual preparation of radiopharmaceuticals. 2\) Nuclear medicine healthcare professionals without experience in radiopharmaceutical administration. 3\) Inability to provide written informed consent.

Design outcomes

Primary

MeasureTime frame
Change in absorbed dose by radiographers during PET/CT procedures, measured in millisieverts (mSv).3 months

Countries

Italy

Contacts

Primary ContactGiuseppe Bonfitto
bonfitto.giuseppe@hsr.it02-26438384
Backup ContactSerena Pichierri
pichierri.serena@hsr.it02-26438384

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026